TERT promoter mutation status is an independent prognostic factor in cutaneous melanoma

被引：0

作者：

Griewank, K. ^{[1
]}

Murali, R. ^{[2
]}

Puig-Butille, J. ^{[3
]}

Schilling, B. ^{[1
]}

Livingstone, E. ^{[1
]}

Potrony, M. ^{[3
]}

Carrera, C. ^{[3
]}

Schimming, T. ^{[1
]}

Moeller, I. ^{[1
]}

Schwamborn, M. ^{[1
]}

Sucker, A. ^{[1
]}

Hillen, U. ^{[1
]}

Badenas, C. ^{[3
]}

Malvehy, J. ^{[3
]}

Zimmer, L. ^{[1
]}

Scherag, A. ^{[4
]}

Puig, S. ^{[3
]}

Schadendorf, D. ^{[1
]}

机构：

[1] Univ Klinikum Essen, Hautklin, Essen, Germany

[2] Mem Sloan Kettering, Pathol, New York, NY USA

[3] Univ Barcelona, Barcelona, Spain

[4] Univ Jena, Jena, Germany

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2014年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

FV11

引用

页码：5 / 5

页数：1

共 50 条

[41] Breslow density is an independent prognostic factor that has potential value for upstaging cutaneous malignant melanoma
Saldanha, G.
Yarrow, J.
Pancholi, J.
Rashed, H.
Bamford, M.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 : 130 - 130
[42] TERT PROMOTER MUTATION IS AN INDEPENDENT PROGNOSTIC FACTOR IN 1P/19Q CO-DELETED OLIGODENDROGLIOMAS: A POLA NETWORK STUDY
Alentorn, A.
Carpentier, C.
Labreche, K.
Ducray, F.
Dehais, C.
Mokhtari, K.
Uro-Coste, E.
Figarella-Branger, D.
Delattre, J.
Idbaih, A.
[J]. NEURO-ONCOLOGY, 2016, 18 : 32 - 33
[43] CONFIRMATION OF TERT PROMOTER MUTATION AS A PROGNOSTIC MARKER IN A GREEK COHORT WITH GLIOMA
Vernadou, A.
Nasioulas, G.
Rigakos, G.
Papadopoulos, S.
Tsimpidakis, A.
Nomikos, P.
Lampropoulos, S.
Razis, E.
[J]. NEURO-ONCOLOGY, 2017, 19 : 31 - 31
[44] Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
Tunthanathip, Thara
Sangkhathat, Surasak
Tanvejsilp, Pimwara
Kanjanapradit, Kanet
[J]. JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2021, 12 (04) : 694 - 703
[45] Prognostic impact of BRAF-V600E expression and correlation with mutation status in cutaneous melanoma
Hugdahl, Emilia
Kalvenes, May Britt
Puntervill, Hanne
Ladstein, Rita
Akslen, Lars A.
[J]. CANCER RESEARCH, 2016, 76
[46] Prognostic role of BRAF mutation in malignant cutaneous melanoma.
Sehdev, Amikar
Hayden, Ross
Kuhar, Mathew Joseph
Cheng, Liang
Warren, Simon John
Mark, Lawrence Aaron
Wooden, William Arthur
Schwartzentruber, Douglas Jay
Logan, Theodore F.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[47] Breslow Density as an Independent Prognostic Indicator in Cutaneous Malignant Melanoma
Rashed, H.
Bamford, M.
Flatman, K.
Teo, K. W. W.
Saldanha, G.
[J]. JOURNAL OF PATHOLOGY, 2016, 240 : 47 - 47
[48] Tumor Necrosis Is a Prognostic Factor in Thick Cutaneous Melanoma
Ladstein, Rita Grude
Bachmann, Ingeborg Margrethe
Straume, Oddbjorn
Akslen, Lars Andreas
[J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (10) : 1477 - 1482
[49] Tumor Volume: An Adjunct Prognostic Factor in Cutaneous Melanoma
Walton, Robert G.
Kim, Jinah
Velasco, Cruz
Swetter, Susan M.
[J]. CUTIS, 2014, 94 (05): : 226 - 230
[50] SENTINEL NODE BIOPSY AS A PROGNOSTIC FACTOR IN CUTANEOUS MELANOMA
Aviles-Izquierdo, J. A.
Lazaro-Ochaita, P.
[J]. ACTAS DERMO-SIFILIOGRAFICAS, 2009, 100 (06): : 486 - 492

← 1 2 3 4 5 →